Product List     API & Intermediate     

Pharmaceutical Intermediates

Find
3903
related chemicals for you
CAS:2680-03-7
Molecular Formula:C5H9NO
Acrylamide, N,N-Dimethyl-; Acylamide, N,N-Dimethyl; Dimethylamid Kyseliny Akrylove; Dimethylamidkyselinyakrylove; N,N-Dimethyl-2-Propenamid; Acryloyldimethylamine; N,N-Dimethylpropenamide; 2-Propenamide, N,N-Dimethyl-
Brief Introduction
This product is easy to produce polymers with high degree of polymerization, and can be copolymerized with acrylic monomers, styrene, vinyl acetate, etc. Polymers or adducts have excellent hygroscopicity, antistatic property, dispersion, compatibility, protective stability and adhesion.
CAS:304-55-2
Molecular Formula:C4H6O4S2
(2R,3S)-2,3-Dimercaptosuccinic Acid; (2R,3S)-Rel-2,3-Dimercaptosuccinic Acid; Succimer; Butanedioic Acid,2,3-Dimercapto-, (2R,3S)-Rel-; Meso-2,3-Dimercaptosuccinic Acid; Api Succimer; -Rel-2,3-Dimercaptosuccinic Acid; (2S,3R)-2,3-Dimercaptobutanedioate; (R*,S*)-2,3-Dimercaptobutanedioicacid
Brief Introduction
It is a selective masking agent for cadmium and used for EDTA titration of zinc.
CAS:32384-65-9
Molecular Formula:C18H42O6Si4
(3R,4S,5R,6R)-3,4,5-Tris(Trimethylsilyloxy)-6-(Trimethylsilyloxymethyl)Tetrahydropyran-2-One; (3R,4S,5R,6R)-3,4,5-Tris(Trimethylsilyloxy)-6-((Trimethylsilyloxy)Methyl)Tetrahydro-2H-Pyran-2-One; 2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Glucono-1,5-Lactone; (3R,4S,5R,6R)-3,4,5-Tris(Trimethylsilyloxy)-6-(Trimethylsilyloxymethyl)Oxan-2-One; 2,3,4,6-Tetrakis-O Trimethylsilyl-D-Gluconolactone; (3R,4S,5R,6R)-3,4,5-tris(Trimethylsilyloxy)-6-(Trimethylsilyloxy)Methyl)Tetrahydro-2H-Pyran-2-one
Brief Introduction
2,3,4,6-tetrakis-O-trimethylsilyl-D-glucono-1,5-lactone are antidiabetic agents and intermediates of Da Glenn Jing. 2,3,4,6-tetrakis-O-trimethylsilyl-D-glucono-1,5-lactone was used as a reagent for the synthesis of C-glucose containing trans cyclohexane and as a sodium glucose cotransporter 2 inhibitor.
CAS:444731-75-3
Molecular Formula:C14H14ClN5
2,3-Dimethyl-N-(2-Chloropyrimidin-4-Yl)-N-Methyl-2H-Indazol-6-Amine; N-(2-Chloropyrimidin-4-Yl)-N,2,3-Trimethylindazol-6-Amine; N-(2-Chloro-4-Pyrimidinyl)-N,2,3-Trimethyl-2H-Indazol-6-Amine; 2H-Indazol-6-Amine, N-(2-Chloro-4-Pyrimidinyl)-N,2,3-Trimethyl-
Brief Introduction
N-(2-Chloro-4-pyrimidinyl)-N,2,3-trimethyl-2H-indazol-6-amine is an impurity of Pazopanib, an oral angiogenesis inhibitor targeting VEGFR and PDGFR.
8-Bromo-7-(but-2-yn-1-yl)-3-Methyl-1-[(4-Methylquinazolin-2-yl)Methyl]-3,7-Dihydro-1H-Purine-2,6-Dione; 1-[(4-Methylquinazolin-2-yl)Methyl]-3-Methyl-7-(2-Butyn-1-yl)-8-Bromoxanthine; 8-Bromo-7-(2-Butyn-1-yl)-3,7-Dihydro-3-Methyl-1-[(4-Methyl-2-Quinazolinyl)Methyl]-1H-Purine-2,6-Dione; 8-Bromo-7-but-2-ynyl-3-Methyl-1-[(4-Methylquinazolin-2-yl)Methyl]Purine-2,6-Dione; Iinagliptin Intermediate
Brief Introduction
Linagliptin intermediates
Inquiry ( 
10
 
/ 10
 )
Clear All
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >